ARTICLE | Company News
Dual Therapeutics, Bristol-Myers deal
January 25, 2016 8:00 AM UTC
Dual Therapeutics granted Bristol-Myers Squibb exclusive, worldwide rights to develop and commercialize preclinical small molecule therapeutics. BMS has rights for all indications but will focus on ca...